Iser, S.; Hintermair, S.; Varga, A.; Çelik, A.; Sayan, M.; Kankoç, A.; Akyürek, N.; Öğüt, B.; Bertoglio, P.; Capozzi, E.;
et al. Validation of Inflammatory Prognostic Biomarkers in Pleural Mesothelioma. Cancers 2024, 16, 93.
https://doi.org/10.3390/cancers16010093
AMA Style
Iser S, Hintermair S, Varga A, Çelik A, Sayan M, Kankoç A, Akyürek N, Öğüt B, Bertoglio P, Capozzi E,
et al. Validation of Inflammatory Prognostic Biomarkers in Pleural Mesothelioma. Cancers. 2024; 16(1):93.
https://doi.org/10.3390/cancers16010093
Chicago/Turabian Style
Iser, Stephanie, Sarah Hintermair, Alexander Varga, Ali Çelik, Muhammet Sayan, Aykut Kankoç, Nalan Akyürek, Betül Öğüt, Pietro Bertoglio, Enrico Capozzi,
and et al. 2024. "Validation of Inflammatory Prognostic Biomarkers in Pleural Mesothelioma" Cancers 16, no. 1: 93.
https://doi.org/10.3390/cancers16010093
APA Style
Iser, S., Hintermair, S., Varga, A., Çelik, A., Sayan, M., Kankoç, A., Akyürek, N., Öğüt, B., Bertoglio, P., Capozzi, E., Solli, P., Ventura, L., Waller, D., Weber, M., Stubenberger, E., & Ghanim, B.
(2024). Validation of Inflammatory Prognostic Biomarkers in Pleural Mesothelioma. Cancers, 16(1), 93.
https://doi.org/10.3390/cancers16010093